Literature DB >> 14755028

Managing recurrent bacterial vaginosis.

J Wilson1.   

Abstract

Bacterial vaginosis (BV) is the most frequently found condition of the female genital tract. It increases a woman's risk of acquiring HIV, is associated with increased complications in pregnancy, and may be involved in the pathogenesis of pelvic inflammatory disease. Yet there are many unanswered questions about its aetiology, making management of recurrent infection difficult and often idiosyncratic. This paper discusses the current knowledge and possible management of recurrent BV.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14755028      PMCID: PMC1758381          DOI: 10.1136/sti.2002.002733

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  29 in total

1.  Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora.

Authors:  D A Eschenbach; S S Thwin; D L Patton; T M Hooton; A E Stapleton; K Agnew; C Winter; A Meier; W E Stamm
Journal:  Clin Infect Dis       Date:  2000-06-13       Impact factor: 9.079

2.  Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified non-specific vaginitis.

Authors:  H L GARDNER; C D DUKES
Journal:  Am J Obstet Gynecol       Date:  1955-05       Impact factor: 8.661

3.  Treatment of bacterial vaginosis.

Authors:  P G Larsson
Journal:  Int J STD AIDS       Date:  1992 Jul-Aug       Impact factor: 1.359

4.  Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification.

Authors:  E R Boskey; K M Telsch; K J Whaley; T R Moench; R A Cone
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

5.  Sexual behavior risk factors associated with bacterial vaginosis and Chlamydia trachomatis infection.

Authors:  U Nilsson; D Hellberg; M Shoubnikova; S Nilsson; P A Mårdh
Journal:  Sex Transm Dis       Date:  1997-05       Impact factor: 2.830

6.  Growth inhibition of metronidazole-susceptible and metronidazole-resistant strains of Gardnerella vaginalis by Lactobacilli in vitro.

Authors:  N W McLean; J A McGroarty
Journal:  Appl Environ Microbiol       Date:  1996-03       Impact factor: 4.792

7.  Factors associated with acquisition of, or persistent colonization by, vaginal lactobacilli: role of hydrogen peroxide production.

Authors:  A C Vallor; M A Antonio; S E Hawes; S L Hillier
Journal:  J Infect Dis       Date:  2001-10-30       Impact factor: 5.226

Review 8.  Bacterial vaginosis: review of treatment options and potential clinical indications for therapy.

Authors:  M R Joesoef; G P Schmid; S L Hillier
Journal:  Clin Infect Dis       Date:  1999-01       Impact factor: 9.079

9.  Treatment of bacterial vaginosis with lactobacilli.

Authors:  A Hallén; C Jarstrand; C Påhlson
Journal:  Sex Transm Dis       Date:  1992 May-Jun       Impact factor: 2.830

10.  Efficacy of the combination of 2 g oral tinidazole and acidic buffering vaginal gel in comparison with vaginal clindamycin alone in bacterial vaginosis: a randomized, investigator-blinded, controlled trial.

Authors:  Massimo Milani; Eliana Barcellona; Antonella Agnello
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2003-07-01       Impact factor: 2.435

View more
  27 in total

1.  Multiplex detection of bacteria in complex clinical and environmental samples using oligonucleotide-coupled fluorescent microspheres.

Authors:  Tim J Dumonceaux; Jennifer R Town; Janet E Hill; Bonnie L Chaban; Sean M Hemmingsen
Journal:  J Vis Exp       Date:  2011-10-23       Impact factor: 1.355

2.  Findings associated with recurrence of bacterial vaginosis among adolescents attending sexually transmitted diseases clinics.

Authors:  Rebecca M Brotman; Emily J Erbelding; Roxanne M Jamshidi; Mark A Klebanoff; Jonathan M Zenilman; Khalil G Ghanem
Journal:  J Pediatr Adolesc Gynecol       Date:  2007-08       Impact factor: 1.814

Review 3.  Life in the littoral zone: lactobacilli losing the plot.

Authors:  P Hay
Journal:  Sex Transm Infect       Date:  2005-04       Impact factor: 3.519

Review 4.  Vaginal discharge.

Authors:  Des Spence; Catriona Melville
Journal:  BMJ       Date:  2007-12-01

Review 5.  Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies.

Authors:  Julius Atashili; Charles Poole; Peter M Ndumbe; Adaora A Adimora; Jennifer S Smith
Journal:  AIDS       Date:  2008-07-31       Impact factor: 4.177

Review 6.  Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections.

Authors:  D K Hickey; M V Patel; J V Fahey; C R Wira
Journal:  J Reprod Immunol       Date:  2011-02-26       Impact factor: 4.054

7.  The posttrial effect of oral periodic presumptive treatment for vaginal infections on the incidence of bacterial vaginosis and Lactobacillus colonization.

Authors:  Jennifer E Balkus; Walter Jaoko; Kishorchandra Mandaliya; Barbra A Richardson; Linnet Masese; Ruth Gitau; James Kiarie; Jeanne Marrazzo; Carey Farquhar; R Scott McClelland
Journal:  Sex Transm Dis       Date:  2012-05       Impact factor: 2.830

8.  Drawing the line between commensal and pathogenic Gardnerella vaginalis through genome analysis and virulence studies.

Authors:  Michael D Harwich; Joao M Alves; Gregory A Buck; Jerome F Strauss; Jennifer L Patterson; Aminat T Oki; Philippe H Girerd; Kimberly K Jefferson
Journal:  BMC Genomics       Date:  2010-06-11       Impact factor: 3.969

9.  Pyrosequencing of the chaperonin-60 universal target as a tool for determining microbial community composition.

Authors:  John Schellenberg; Matthew G Links; Janet E Hill; Tim J Dumonceaux; Geoffrey A Peters; Shaun Tyler; T Blake Ball; Alberto Severini; Francis A Plummer
Journal:  Appl Environ Microbiol       Date:  2009-03-06       Impact factor: 4.792

Review 10.  The rationale for probiotics in female urogenital healthcare.

Authors:  Gregor Reid; Jeremy Burton; Estelle Devillard
Journal:  MedGenMed       Date:  2004-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.